| | |
MedLine Citation:
|
PMID: 21751759 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
A Paris court handed down its ruling on 2 March, rejecting a suit brought by pharmaceutical company Astellas against the French journal Prescrire. At a time when French society is reeling in the wake of the scandal caused by weight-loss drug Mediator (benfluorex), the 2 March ruling comes as very good news for healthcare professionals and for patients. |
| | |
Authors:
|
- |
Related Documents
:
|
20194289 - Ethics consultation in children's hospitals: results from a survey of pediatric clinica... 12600319 - Sas-4 is a c. elegans centriolar protein that controls centrosome size. 22570569 - Ethical principles for project collaboration between academic professionals or institut... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Prescrire international Volume: 20 ISSN: 1167-7422 ISO Abbreviation: Prescrire Int Publication Date: 2011 Jul-Aug |
Date Detail:
|
Created Date: 2011-07-14 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9439295 Medline TA: Prescrire Int Country: France |
Other Details:
|
Languages: eng Pagination: 191 Citation Subset: T |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Retinal vein occlusion.
Next Document: Measuring survival time: a probability-based approach useful in healthcare decision-making.